Francesco Galimi M.D., Ph.D.
Net Worth
Last updated:
What is Francesco Galimi M.D., Ph.D. net worth?
The estimated net worth of Dr. Francesco Galimi M.D., Ph.D. is at least $3,063,978 as of 4 Apr 2022. He owns shares worth $41,942 as insider, has earned $197,316 from insider trading and has received compensation worth at least $2,824,720 in Adicet Bio, Inc..
What is the salary of Francesco Galimi M.D., Ph.D.?
Dr. Francesco Galimi M.D., Ph.D. salary is $706,180 per year as Chief Medical Officer & Senior Vice President in Adicet Bio, Inc..
How old is Francesco Galimi M.D., Ph.D.?
Dr. Francesco Galimi M.D., Ph.D. is 57 years old, born in 1968.
What stocks does Francesco Galimi M.D., Ph.D. currently own?
As insider, Dr. Francesco Galimi M.D., Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Adicet Bio, Inc. (ACET) | Chief Medical Officer & Senior Vice President | 59,917 | $0.7 | $41,942 |
What does Adicet Bio, Inc. do?
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
Francesco Galimi M.D., Ph.D. insider trading
Adicet Bio, Inc.
Dr. Francesco Galimi M.D., Ph.D. has made 2 insider trades between 2021-2022, according to the Form 4 filled with the SEC. Most recently he sold 1,775 units of ACET stock worth $37,275 on 4 Apr 2022.
The largest trade he's ever made was exercising 7,621 units of ACET stock on 1 Apr 2022. As of 4 Apr 2022 he still owns at least 59,917 units of ACET stock.
Adicet Bio key executives
Adicet Bio, Inc. executives and other stock owners filed with the SEC:
- Dr. Aya Jakobovits Ph.D. (72) Founder & Independent Director
- Dr. Francesco Galimi M.D., Ph.D. (57) Chief Medical Officer & Senior Vice President
- Mr. Chen Schor BA, CPA, CPA, M.B.A., MBA (53) Chief Executive Officer, Pres & Director